149 related articles for article (PubMed ID: 33979728)
1. Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada.
Gupta S; Sutradhar R; Li Q; Athale U; Bassal M; Breakey V; Gibson PJ; Patel S; Silva M; Zabih V; Pechlivanoglou P; Pole JD; Mittmann N
Eur J Cancer; 2021 Jul; 151():126-135. PubMed ID: 33979728
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of treatment for acute lymphoblastic leukaemia in childhood.
Rae C; Furlong W; Jankovic M; Moghrabi A; Naqvi A; Sala A; Samson Y; DePauw S; Feeny D; Barr R
Eur J Cancer Care (Engl); 2014 Nov; 23(6):779-85. PubMed ID: 24393150
[TBL] [Abstract][Full Text] [Related]
3. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
4. Phase-specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group-based treatment for childhood acute lymphoblastic leukemia: A population-based study.
Bassal M; Silva M; Patel S; Gibson PJ; Breakey VR; Athale U; Zabih V; Li Q; Pechlivanoglou P; Pole JD; Mittmann N; Sutradhar R; Gupta S
Pediatr Blood Cancer; 2021 Oct; 68(10):e29141. PubMed ID: 34003566
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of rituximab in addition to standard of care chemotherapy for adult patients with acute lymphoblastic leukemia.
Nam J; Milenkovski R; Yunger S; Geirnaert M; Paulson K; Seftel M
J Med Econ; 2018 Jan; 21(1):47-59. PubMed ID: 28837377
[TBL] [Abstract][Full Text] [Related]
6. Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.
Desai SJ; Barr RD; Andrew M; deVeber LL; Pai MK
CMAJ; 1989 Oct; 141(7):693-7. PubMed ID: 2790605
[TBL] [Abstract][Full Text] [Related]
7. Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH; Fisher BT; Gerbing R; Grundmeier RW; Krause EM; Lee J; Lupo PJ; Rabin KR; Ramos M; Scheurer ME; Wilkes JJ; Winestone LE; Hawkins DS; Gramatges MM; Aplenc R
Lancet Haematol; 2022 Sep; 9(9):e678-e688. PubMed ID: 35870472
[TBL] [Abstract][Full Text] [Related]
8. Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232.
DiNofia AM; Seif AE; Devidas M; Li Y; Hall M; Huang YV; Cahen V; Hunger SP; Winick NJ; Carroll WL; Fisher BT; Larsen EC; Aplenc R
Cancer Med; 2018 Jan; 7(1):3-12. PubMed ID: 29274118
[TBL] [Abstract][Full Text] [Related]
9. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
[TBL] [Abstract][Full Text] [Related]
10. Health Status and Health-related Quality of Life Measurement in Pediatric Cancer Clinical Trials: An Examination of the DFCI 00-01 Acute Lymphoblastic Leukemia Protocol.
Rae C; Furlong W; Feeny D; Couchman R; Silverman L; Sallan S; Laverdiere C; Clavell L; Michon B; Kelly K; Larsen E; Pullenayegum E; Athale U; Barr R
J Pediatr Hematol Oncol; 2018 Nov; 40(8):580-587. PubMed ID: 29901560
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
Athale UH; Siciliano SA; Crowther M; Barr RD; Chan AK
Br J Haematol; 2005 Jun; 129(6):803-10. PubMed ID: 15953008
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia.
Sulis ML; Blonquist TM; Stevenson KE; Hunt SK; Kay-Green S; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JG; Neuberg DS; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 May; 65(5):e26952. PubMed ID: 29319209
[TBL] [Abstract][Full Text] [Related]
13. Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.
Athale UH; Puligandla M; Stevenson KE; Asselin B; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Sulis ML; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2018 Oct; 65(10):e27256. PubMed ID: 29878490
[TBL] [Abstract][Full Text] [Related]
14. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
15. Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols.
Niemeyer CM; Reiter A; Riehm H; Donnelly M; Gelber RD; Sallan SE
Ann Oncol; 1991; 2(10):745-9. PubMed ID: 1801880
[TBL] [Abstract][Full Text] [Related]
16. Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without Down syndrome.
Athale U; Sutradhar R; Breakey VR; Li Q; Bassal M; Gibson P; Patel S; Wheaton L; Pole JD; Mittman N; Pechlivanoglou P; Gupta S
Pediatr Blood Cancer; 2022 Oct; 69(10):e29829. PubMed ID: 35674471
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).
Silverman LB; Stevenson KE; O'Brien JE; Asselin BL; Barr RD; Clavell L; Cole PD; Kelly KM; Laverdiere C; Michon B; Schorin MA; Schwartz CL; O'Holleran EW; Neuberg DS; Cohen HJ; Sallan SE
Leukemia; 2010 Feb; 24(2):320-34. PubMed ID: 20016537
[TBL] [Abstract][Full Text] [Related]
18. Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies.
Gaynon PS; Bostrom BC; Hutchinson RJ; Lange BJ; Nachman JB; Steinherz PG; Sensel MG; Lee MK; Stram DO; Sather HN
J Clin Oncol; 2001 Apr; 19(7):1916-25. PubMed ID: 11283123
[TBL] [Abstract][Full Text] [Related]
19. [Acute lymphoblastic leukemia in childhood. A 10-year experience with the DFCI 81-01 protocol].
de Lacerda AF; Chagas M; Neto A; Vieira E; Ribeiro MJ; Pereira F; Ambrósio A; Sousinha M
Acta Med Port; 1999; 12(7-11):287-92. PubMed ID: 10707467
[TBL] [Abstract][Full Text] [Related]
20. Cost analysis of the treatment of acute childhood lymphocytic leukaemia according to Nordic protocols.
Rahiala J; Riikonen P; Kekäläinen L; Perkkiö M
Acta Paediatr; 2000 Apr; 89(4):482-7. PubMed ID: 10830464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
